With every passing day, new discoveries are made that lend support to the increasing and important role biomarker analysis and tumor profiling play in personalized cancer care. Caris Life Sciences® is actively participating in research to advance the understanding of molecular science, further enabling the delivery of precision medicine.

Plasma Exosome Profiling of Cancer Patients by a Next Generation Systems Biology Approach

Molecular Variances Between Rectal and Left-Sided Colon Cancers (Presentation)

Molecular Variances Between Rectal and Left Sided Colon Cancers

Molecular characterization of squamous cell carcinoma of the anal canal (SCCA)

Molecular Characterization of Early vs. Late Onset Gastroesophageal Cancer

Characterization of Tumor Mutation Burden (TMB) in Gastrointestinal (GI) Cancers

Racial differences in the molecular landscape of breast cancer

Use of an aptamer library based next generation omics platform for the development of a novel trastuzumab

Programmed death 1 (PD-1) and PD-1 ligand (PD-L1) distribution in triple negative breast cancer TNBC

ESR1 mutations, ESR1 fusions and co-occurring alterations assessed in breast cancer tumors